![]() |
市場調查報告書
商品編碼
1451517
2024-2032 年代懷孕市場報告(按類型(妊娠代孕、傳統代孕)、技術(IVF 與 ICSI、IVF 與 ICSI、子宮內人工授精)、服務提供者(醫院、生育診所等)和地區Surrogacy Market Report by Type (Gestational Surrogacy, Traditional Surrogacy), Technology (IVF with ICSI, IVF without ICSI, Intrauterine Insemination), Service Provider (Hospitals, Fertility Clinics, and Others), and Region 2024-2032 |
2023年全球代孕市場規模達1.834億美元。展望未來, IMARC Group預計到2032年市場規模將達到3.069億美元,2024-2032年複合年成長率(CAGR)為5.8%。生育旅遊的迅速擴張、受孕困難的增加、具有成本效益的代孕的容易獲得以及許多國家管理當局提供的優惠報銷政策是推動該市場的一些主要因素。
代孕是一種生殖安排,其中被稱為代孕者或懷孕攜帶者的婦女同意為另一個人或夫婦懷孕和生下孩子。面臨生育挑戰或阻止懷孕的醫療狀況的個人或夫婦經常尋求這種方法。代孕有兩種主要類型:傳統代孕,使用代孕媽媽的卵子;妊娠代孕,使用預期母親的卵子或捐贈卵子創建胚胎,然後植入代孕媽媽的子宮。代孕涉及法律協議、醫療程序和情感考慮,其合法性因司法管轄區而異。
人們對生育挑戰的認知不斷增強,對非傳統家庭結構的接受度不斷提高,將刺激預測期內代孕市場的成長。面臨生殖障礙的夫妻和個人將代孕視為滿足其為人父母願望的可行解決方案。此外,生殖技術和醫療程序的許多進步,加上某些地區法律框架的改進,促進了更安全、更可靠的代孕安排,正在對市場成長產生積極影響。除此之外,快速的全球化和便利的國際旅行使有意父母能夠在監管有利且成本較低的國家探索代孕選擇,從而推動市場成長。此外,不斷成長的支持網路、倡導團體和線上平台為那些考慮代孕的人提供資訊和情感幫助,加快了產品的採用率。此外,不斷發展的延遲生育文化轉變和不孕症病例的增加也促進了市場的成長。
提高接受度和意識
由於代孕作為成為父母的合法途徑的接受度和意識不斷增強,代孕市場正在經歷一場變革。隨著社會態度的不斷變化和對生育挑戰的更加開放的討論,代孕在全球範圍內獲得了巨大的信譽和認可。這一趨勢的基礎是人們對多樣化家庭結構的日益認知以及接受替代生殖方法的意願增強。因此,越來越多的個人和夫婦正在探索代孕作為可行的解決方案,為代孕服務創造了更廣泛、更容易接受的市場。
醫療科技的進步
醫療技術的重大進步徹底改變了代孕格局。體外受精(IVF)和妊娠代孕等技術在世界各地變得越來越複雜和容易取得。這些創新可以精確控制代孕過程,有助於提高代孕母親和預期父母的成功率並降低醫療風險。先進的產前檢測和醫學監測進一步提高代孕安排的安全性和成功率。這一趨勢使個體面臨生育挑戰,並將代孕定位為更廣泛的輔助生殖領域中更可行和更有效的選擇。
跨國代孕安排不斷增加
由於不同國家代孕法律的差異,代孕市場的特徵是跨國安排顯著增加。來自代孕法規受到限制的各國的意向父母正在法律環境更有利的司法管轄區尋求代孕服務。這刺激了對專家諮詢服務的需求,以應對國際代孕過程中複雜的法律、文化和後勤考慮。它強調了代孕市場的全球性,並強調在尋求跨國代孕時採取明智方法的必要性,確保遵守法律框架,同時維護所有相關利害關係人的利益。
The global surrogacy market size reached US$ 183.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 306.9 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The rapid expansion of fertility tourism, rising inability to conceive, easy availability of cost-effective surrogacy, and favorable reimbursement policies offered by governing authorities of numerous countries are some of the major factors propelling the market.
Surrogacy is a reproductive arrangement in which a woman, known as the surrogate or gestational carrier, agrees to carry and give birth to a child for another individual or couple. This method is often sought by individuals or couples facing fertility challenges or medical conditions that prevent pregnancy. There are two primary types of surrogacy: traditional surrogacy, where the surrogate's egg is used, and gestational surrogacy, where the embryo is created using either the intended mother's egg or a donor egg, and then implanted into the surrogate's uterus. Surrogacy involves legal agreements, medical procedures, and emotional considerations, and its legality varies across jurisdictions.
The increasing awareness of fertility challenges and the rising acceptance of non-traditional family structures will stimulate the growth of the surrogacy market during the forecast period. Couples and individuals facing reproductive obstacles see surrogacy as a viable solution to fulfill their desire for parenthood. Moreover, numerous advancements in reproductive technologies and medical procedures, coupled with improved legal frameworks in certain regions, that facilitate safer and more reliable surrogacy arrangements are positively influencing the market growth. Apart from this, rapid globalization and ease of international travel have enabled intended parents to explore surrogacy options in countries with favorable regulations and lower costs, thereby propelling the market growth. Additionally, the growing support networks, advocacy groups, and online platforms provide information and emotional assistance to those considering surrogacy has accelerated the product adoption rate. Furthermore, the evolving cultural shift toward delayed parenthood and the rising instances of infertility are contributing to the market growth.
Increasing Acceptance and Awareness
The surrogacy market is experiencing a transformative shift due to the expanding acceptance and awareness of surrogacy as a legitimate path to parenthood. With evolving social attitudes and a more open discourse around fertility challenges, surrogacy has gained immense credibility and recognition across the globe. This trend is underpinned by a growing recognition of diverse family structures and an increased willingness to embrace alternative reproductive methods. As a result, more individuals and couples are exploring surrogacy as a viable solution, creating a broader and more receptive market for surrogacy services.
Advancements in medical technology
The surrogacy landscape has been revolutionized by significant advancements in medical technology. Techniques such as in vitro fertilization (IVF) and gestational surrogacy have become increasingly sophisticated and accessible worldwide. These innovations enable precise control over the surrogacy process, contributing to improved success rates and reduced medical risks for both surrogate mothers and intended parents. Advanced prenatal testing and medical monitoring further enhance the safety and success of surrogacy arrangements. This trend empowers individuals with fertility challenges and positions surrogacy as a more viable and efficient option within the broader spectrum of assisted reproduction.
Rising cross-border surrogacy arrangements
The surrogacy market is marked by a notable rise in cross-border arrangements, driven by the disparities in surrogacy laws across different countries. Intended parents from various nations with restrictive surrogacy regulations are seeking surrogacy services in jurisdictions with more favorable legal environments. This has spurred the need for expert consulting services that navigate the complex web of legal, cultural, and logistical considerations in international surrogacy journeys. It underscores the global nature of the surrogacy market and emphasizes the necessity for a well-informed approach when pursuing cross-border surrogacy, ensuring compliance with legal frameworks while safeguarding the interests of all stakeholders involved.
IMARC Group provides an analysis of the key trends in each segment of the global surrogacy market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, technology and service provider.
Gestational Surrogacy
Traditional Surrogacy
Gestational surrogacy dominates the market
The report has provided a detailed breakup and analysis of the market based on the type. This includes gestational surrogacy and traditional surrogacy. According to the report, gestational surrogacy represented the largest segment.
Gestational surrogacy method, where a surrogate carries a pregnancy conceived using the intended parents' or donors' eggs and sperm, offers distinct advantages. It minimizes genetic ties between the surrogate and the child, addressing legal and emotional complexities. Gestational surrogacy also opens doors for individuals and couples facing fertility challenges, same-sex couples, and those seeking genetic diversity.
Moreover, the increasing precision of assisted reproductive technologies, such as in vitro fertilization (IVF), is propelling the success rates of gestational surrogacy. As a result, it provides a viable solution for intended parents and fosters a broader acceptance of surrogacy due to its streamlined legal and genetic frameworks, thus playing a pivotal role in driving the market forward.
IVF with ICSI
IVF without ICSI
Intrauterine Insemination
IVF with ICSI holds the largest share in the market
A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes IVF with ICSI, IVF without ICSI, and intrauterine insemination. According to the report, IVF with ICSI accounted for the largest market share.
IVF with Intracytoplasmic Sperm Injection (ICSI) is an advanced assisted reproductive technique that addresses male infertility challenges by directly injecting a single sperm into an egg, optimizing fertilization. This precision enhances the chances of obtaining viable embryos for transfer, thus increasing the success rates of surrogacy arrangements. IVF with ICSI enables intended parents to overcome complex fertility issues, expanding the pool of potential clients for surrogacy services.
Moreover, the higher success rates associated with this technique encourage intended parents to consider surrogacy as a reliable pathway to parenthood, fostering greater demand within the surrogacy market. The integration of IVF with ICSI enhances the medical feasibility of surrogacy and strengthens its reputation as an effective solution, fueling the market growth.
Hospitals
Fertility Clinics
Others
Fertility Clinics represent the most popular service provider
The report has provided a detailed breakup and analysis of the market based on the service provider. This includes hospitals, fertility clinics, and others. According to the report, fertility clinics represented the largest segment.
Fertility clinics play a pivotal role in propelling the market growth by providing essential medical expertise and infrastructure. These clinics offer a spectrum of advanced reproductive technologies, including in vitro fertilization (IVF) and embryo transfer procedures, which are fundamental to surrogacy. Their specialized services cater to individuals and couples facing infertility challenges, making surrogacy a viable option. Fertility clinics provide comprehensive medical assessments, personalized treatment plans, and close monitoring throughout the surrogacy journey, ensuring the best possible outcomes.
Additionally, these clinics often collaborate with surrogacy agencies and legal experts, creating a seamless experience for intended parents and surrogates. As hubs of medical innovation and support, fertility clinics significantly the market growth by enabling successful pregnancies, facilitating family expansion, and nurturing the partnership between intended parents and surrogates.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest share in the market due to its favorable legal, medical, and social landscape. The region's well-established regulatory frameworks in countries like the United States and Canada provide a secure environment for surrogacy arrangements, assuring the rights of intended parents and surrogates, thereby propelling the market growth in North America. Advanced medical facilities and expertise in assisted reproductive technologies, coupled with a culturally accepting environment in North America, attract both domestic and international individuals and couples seeking surrogacy services.
Additionally, the region's diverse population and evolving perspectives on family structures has accelerated the adoption of surrogacy. As a result, North America emerges as a prominent hub within the surrogacy domain, catering to a wide range of intended parents while upholding ethical standards and legal protections.
Key players in the market are driving innovation through a range of strategies. Prominent surrogacy agencies are embracing digital platforms, streamlining communication between intended parents, surrogates, and medical professionals. They are also integrating advanced embryo screening techniques to enhance success rates and reduce the likelihood of genetic disorders. Some key players are exploring eco-friendly practices by incorporating sustainable approaches in fertility treatments. Collaborations with fertility clinics and legal experts are becoming more prevalent to ensure adherence to evolving regulatory frameworks. These innovations collectively underscore the commitment of key players to continually elevate the surrogacy experience through technological, medical, and holistic advancements. We also expect the market to witness new entrants, consolidation of portfolios, and increased collaborations to drive healthy competition within the domain.
Bourn Hall Clinic
CARE Fertility
Circle Surrogacy & Egg Donation
Extraordinary Conceptions
Growing Generations LLC
Houston Fertility Center
IVIRMA Global
Max Healthcare
New Hope Fertility Center
Nova IVF
Ovation Fertility
Scanfert Clinic
In June 2021, Circle Surrogacy & Egg Donation sponsored A Lifetime of Pride and Joy, a campaign that celebrates and encourages family equality by raising awareness around the accessibility of fertility care among the LGBTQ+ population. This impactful campaign is dedicated to the celebration and advancement of family equality, while also shedding light on the crucial aspect of accessible fertility care. By participating in this campaign, Circle Surrogacy takes a resolute stance in promoting inclusivity and understanding, embracing the diversity of modern families.
In June 2023, AHH's Nova IVF Fertility, a pioneering name in the realm of assisted reproductive healthcare, unveiled an ambitious roadmap that envisages the establishment of an impressive network of 100 centers within the next four years. This strategic expansion plan, as reported by the Economic Times, reflects the organization's unwavering commitment to providing accessible and advanced fertility care across India.
In October 2022, Ovation Fertility, a leading name in the field of assisted reproductive technology, unveiled an exciting and transformative partnership with Genomic Prediction. This collaboration marks a significant milestone in the realm of genetic testing, as it promises to not only enhance but also expand the horizons of genetic assessment within the domain of fertility and family planning. The alliance between Ovation(R) Fertility and Genomic Prediction showcases a shared commitment to leveraging cutting-edge scientific advancements to empower intended parents with a deeper understanding of their genetic profile and reproductive options.